John Vassiliadis

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Emergency Department

Advanced Non Small Cell Lung Cancer

Skeletal Muscle

Anti Inflammatory

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alison J Davis, Natasja Brooijmans, Jason D Brubaker, Faith Stevison, Timothy P LaBranche, Faris Albayya, Paul Fleming, Brian L Hodous, Joseph L Kim, Sean Kim, Riadh Lobbardi, Michael Palmer, Michael P Sheets, John Vassiliadis, Ruduan Wang, Brett D Williams, Douglas Wilson, Lan Xu, Xing Julia Zhu, Keith Bouchard, Jeffrey W Hunter, Chris Graul, Elliot Greenblatt, Amira Hussein, Morgan Lyon, Joelle Russo, Rachel Stewart, Marion Dorsch, Timothy J Guzi, Vivek Kadambi, Christoph Lengauer, Andrew P Garner
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Science translational medicine 16 (749) (2024)
Alison J Davis, Natasja Brooijmans, Jason D Brubaker, Faith Stevison, Timothy P LaBranche, Faris Albayya, Paul Fleming, Brian L Hodous, Joseph L Kim, Sean Kim, Riadh Lobbardi, Michael Palmer, Michael P Sheets, John Vassiliadis, Ruduan Wang, Brett D Williams, Douglas Wilson, Lan Xu, Xing Julia Zhu, Keith Bouchard, Jeffrey W Hunter, Chris Graul, Elliot Greenblatt, Amira Hussein, Morgan Lyon, Joelle Russo, Rachel Stewart, Marion Dorsch, Timothy J Guzi, Vivek Kadambi, Christoph Lengauer, Andrew P Garner
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Science translational medicine 16 (749) (2024)